Kotaro Kodama - Eisai Tsukuba Research Department.

基本信息

浏览量：6

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

E7386, a Selective Inhibitor of the Interaction Between Β-Catenin and CREB-binding Protein (CBP), in Combination with Lenvatinib (LEN), Exerts Antitumor Activity in Preclinical Tumor Models with Prior Immune Checkpoint Inhibitor (Ici)-Based Combination Treatment

Satoshi Kawano,Yusuke Adachi,Megumi Kuronishi,Kohta Toshimitsu,Kotaro Kodama,Takayuki Kimura,Masahiko Kume,Jialing Shen,Saori Watanabe Miyano,Akira Yokoi,Junji Matsui,Yu Kato,Yasuhiro Funahashi

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Supplementary Figure S2 from E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models

Saori Watanabe Miyano, Y. Yamamoto,Kotaro Kodama,Yukiko Miyajima,Masaki Mikamoto,Takayuki Nakagawa,Hiroko Kuramochi,Setsuo Funasaka, Shigeaki Nagao,Naoko Hata Sugi,Kiyoshi Okamoto,Yukinori Minoshima,Yusuke Nakatani,Yuki Karoji,Isao Ōhashi,Yoshinobu Yamane, T. Okada,Tomohiro Matsushima, Junji Matsui,Masao Iwata,Toshimitsu Uenaka,Akihiko Tsuruoka

openalex（2023）

引用0浏览0引用

Supplementary Figure Legend from Novel ATP-Competitive MEK Inhibitor E6201 is Effective Against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model

Yoshihiro Narita,Kiyoshi Okamoto,Megumi Ikemori Kawada, K. Takase,Yukinori Minoshima,Kotaro Kodama,Masao Iwata, Naokazu Miyamoto,Kohei Sawada

openalex（2023）

引用0浏览0引用

Supplementary Figure 1 from Novel ATP-Competitive MEK Inhibitor E6201 is Effective Against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model

Yoshihiro Narita,Kiyoshi Okamoto,Megumi Ikemori Kawada, K. Takase,Yukinori Minoshima,Kotaro Kodama,Masao Iwata, Naokazu Miyamoto,Kohei Sawada

openalex

引用0浏览0引用

Supplementary Document from Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies

Yusuke Adachi, Hiroshi Kamiyama,Kenji Ichikawa,Sayo Fukushima,Yoichi Ozawa,Shogo Yamaguchi,Satoshi Goda,Takayuki Kimura,Kotaro Kodama,Masahiro Matsuki,Saori Watanabe Miyano,Akira Yokoi,Yu Kato,Yasuhiro Funahashi

openalex（2023）

引用0浏览0引用

Supplementary Figure 3 from Novel ATP-Competitive MEK Inhibitor E6201 is Effective Against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model

Yusuke Narita,Kiyoshi Okamoto,Megumi Ikemori Kawada,Kazuma Takase,Yukinori Minoshima,Kotaro Kodama,Masao Iwata,Norimasa Miyamoto,Kohei Sawada

crossref（2023）

引用0浏览0引用

Abstract 1830: E7386, a Selective Inhibitor of the Interaction Between Β-Catenin and CREB-binding Protein (CBP), in Combination with Lenvatinib (LEN), Exerts Antitumor Activity in Preclinical Tumor Models with Prior Immune Checkpoint Inhibitor (Ici)-Based Combination Treatment

Satoshi Kawano,Yusuke Adachi,Megumi Kuronishi,Kohta Toshimitsu,Kotaro Kodama,Takayuki Kimura,Masahiko Kume,Jialing Shen,Saori Watanabe Miyano,Akira Yokoi,Junji Matsui,Yu Kato,Yasuhiro Funahashi

Cancer Researchno. 7_Supplement (2023): 1830-1830

引用0浏览0引用

Supplementary Figure 4 from Novel ATP-Competitive MEK Inhibitor E6201 is Effective Against Vemurafenib-Resistant Melanoma Harboring the MEK1-C121S Mutation in a Preclinical Model

Yoshihiro Narita,Kiyoshi Okamoto,Megumi Ikemori Kawada, K. Takase,Yukinori Minoshima,Kotaro Kodama,Masao Iwata, Naokazu Miyamoto,Kohei Sawada

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn